Back
Open Access

Full guideline-directed medical therapy in heart failure patients with reduced ejection fraction: a real-world analysis in older patients with outcome implication

Session: Prediction and monitoring in heart failure
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor N. Bonini (Modena, IT)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Niccolo Bonini

Modena Polyclinic Modena University Hospital, Modena (Italy)
0 follower

6 more presentations in this session

Are patient demographics, comorbidities, and outcomes in acute decompensated heart failure changing? A comparison of new heart failure programme patients from 2013, 2018, and 2023

Speaker: Doctor L. Maher (Dublin, IE)

Access
Abstract
Like
Thumbnail

Optimizing screening intervals for at-risk family members of dilated cardiomyopathy carrying a titin truncating variant: a multi-state model approach

Speaker: Ms N. Beelen (Maastricht, NL)

Access
Abstract
Like
Thumbnail

Associations of infectious disease and polygenic risk score with heart failure and cardiac remodeling: findings from UK Biobank and ARIC study

Speaker: Mr J. Zheng (Guangzhou, CN)

Access
Abstract
Like
Thumbnail

Socioeconomic and ethnic factors affecting heart failure treatment and prognosis: exploring disparities in clinical outcomes

Speaker: Doctor J. Fernandes Pedro (Lisbon, PT)

Access
Abstract
Like
Thumbnail

Probability scores for heart failure with preserved ejection fraction predict heart failure hospitalization and mortality in patients with unexplained dyspnea

Speaker: Doctor S. Moura Ferreira (Hasselt, BE)

Access
Abstract
Like
Thumbnail

Access the full session

Prediction and monitoring in heart failure

Speakers: Doctor N. Bonini, Doctor L. Maher, Ms N. Beelen, Mr J. Zheng, Doctor J. Fernandes Pedro...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources